(Q44409816)

2 December 2017

title

CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis (English)

1 reference

2 December 2017

0 references

Per Soelberg Sørensen

4

object named as

P Soelberg Sørensen

0 references

Finn Sellebjerg

object named as

F Sellebjerg

1

0 references

author name string

C Ross

2

1 reference

2 December 2017

N Koch-Henriksen

3

1 reference

2 December 2017

J L Frederiksen

5

1 reference

2 December 2017

K Bendtzen

6

1 reference

2 December 2017

T L Sørensen

7

1 reference

2 December 2017

publication date

1 December 2005

1 reference

Multiple Sclerosis Journal

2 December 2017

published in

1 reference

2 December 2017

volume

11

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

641-645

1 reference

CD4 T cell activation and disease activity at onset of multiple sclerosis.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

Effect of relapses on development of residual deficit in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1217OA

10.1191/1352458505MS1217OA

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference